Global Liver Institute Statement on U.S. End-of-Year Health Package
GLI celebrates the release of bill text last night for a continuing resolution (CR) for FY2025 from the U.S. House of Representatives that includes Medicare coverage of multi-cancer early detection screening tests and defines standards and payments for these diagnostic tests.
The Case for Universal Access to Hepatitis C DAA Treatment for Your Patients
Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV) and spread through blood-to-blood exposure. The majority of people exposed to HCV develop chronic infection, which can cause cirrhosis resulting in liver failure, liver cancer, or even the need for liver transplantation.
Can Blood Tests Help Predict Liver Transplant Outcomes? – Pediatric & Rare Liver Diseases News
As we conclude this year, the Pediatric and Rare Liver Diseases team is reflecting on the incredible progress made by our council and patient organizations in 2024.
Congress debates appropriations and other end-of-year legislation. Biden administration issues more rulemakings. Agencies prepare for new leadership. – Liver Health Policy Update
Members of Congress have returned to Washington, DC. It is unclear if many healthcare priorities will make it to final passage this year. The incoming administration has submitted names for its new Cabinet and to lead key agencies.
The Most Common Chronic Liver Disease in the World – Fatty Liver Disease News
Last month, the GLI team proudly attended AASLD’s The Liver Meeting™, starting with our 10th anniversary celebration, which brought together patient advocates, industry leaders, and liver community members to celebrate a decade of impactful work.